Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
77 /100
CRITICAL RISK
Score updated Aug 28, 2026

PDSB — PDS Biotechnology Corporation Dilution Risk Tracker

Track PDSB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PDSB — Get alerts when the score changes →

As of August 28, 2026, PDS Biotechnology Corporation (PDSB) has a DilutionWatch DilutionScore of 77/100, rated CRITICAL dilution risk. PDS Biotechnology Corporation has a market capitalization of $60.28M, 55.97M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $200.00M, 381.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
96
💰 Cash Runway
95
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
💰 Capital Raise model 75%
• Critical: only 1.8 months cash remaining
• Active shelf registration ($200M, 332% of market cap)
🔄 Reverse Split model est. 45%
• 50-day avg $1.00 approaching $1 threshold
• Only 2 months cash — financial pressure
📉 Score Deterioration model 15%
• Score already CRITICAL (77/100) — events likely imminent
🔔 Track PDSB — Get forecast alerts →

Market Data

Market Cap$60.28M
Shares Outstanding55.97M
Float54.40M
Cash$5.60M
Debt$15.00M
Short InterestN/A

Institutional Holdings

10 institutional holders · 7.08M shares
#1 Armistice Capital, LLC 2.83M shares
#2 Vanguard Group Inc 1.95M shares
#3 Blackrock Inc. 522.2K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.83M
Days to Cover10.5
% of Float3.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2020-12-31
8-K 8K EVENT 2026-05-01
EFFECT EFFECT 2026-04-28
S-3/A SHELF 2026-04-24
Full SEC filing analysis available with free account

Recent News

No recent news

Factual PDSB Dilution Snapshot

PDS Biotechnology Corporation (PDSB) has a DilutionScore of 77/100, rated Critical dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track PDSB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PDSB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PDSB
PDSB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.